Ballentine Partners’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Ballentine Partners’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$42.6K	Buy	+10,400	New	+$38.1K	﹤0.01%	1142

Other funds holding DRTSW

MMCAP International Grand Cayman, Cayman Islands $1.52B AUM 24.83% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Mariner Overland Park, Kansas $100B AUM 26.06% 1-Year Est. Return

Circle Wealth Management Summit, New Jersey $8.25B AUM 23.72% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Cohen Investment Advisors Bedford, New Hampshire $233M AUM 21.3% 1-Year Est. Return

Equitec Proprietary Markets Chicago, Illinois $400M AUM 66.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Ballentine Partners's DRTSW Position: Q3 2026 in Review

Ballentine Partners opened a new position in Alpha Tau Medical Warrant (DRTSW) in Q3 2026: 10,400 shares worth $42.6K. The stake represents ﹤0.01% of the portfolio and ranks #1142 among its holdings.

10 funds tracked by Wall St. Rank hold DRTSW as of Q3 2026.

Ballentine Partners held 10,400 shares of Alpha Tau Medical Warrant worth $42.6K as of Q3 2026.
Alpha Tau Medical Warrant was a new Ballentine Partners position in Q3 2026.
Alpha Tau Medical Warrant made up ﹤0.01% of Ballentine Partners's portfolio in Q3 2026, its #1142 holding.
10 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q3 2026.

Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.